Increased risk of cholesteatoma among patients with allergic rhinitis: A nationwide investigation

Chin Lung Kuo, An Suey Shiao, Hsyien Chia Wen, Wei Pin Chang

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

Objectives: No large population-based studies have reported on the risk of cholesteatoma developing after allergic rhinitis (AR). This study used a nationwide population-based claims database to investigate the hypothesis that AR may increase the risk of cholesteatoma. Study Design: Retrospective cohort study. Methods: Data from Taiwan's Longitudinal Health Insurance Database were analyzed to compile the following: 1) 15,953 patients newly diagnosed with AR between 1997 and 2000, and 2) a comparison cohort of 63,812 matched non-AR enrollees (with a ratio of 1 to 4). Each patient was followed for 10 years to identify cases in which cholesteatoma subsequently developed. The Kaplan-Meier method was used to determine the cholesteatoma-free survival rate, and the log-rank test was used to compare survival curves. Cox proportional hazard regressions were performed to compute adjusted hazard ratios (HRs). Results: Among the 79,765 patients enrolled in this study, 45 (159,364 person-years) from the AR cohort and 88 (638,130 person-years) from the comparison cohort were diagnosed with cholesteatoma during the follow-up period (incidence rates 0.28 and 0.14 of 1,000 person-years, respectively). Patients with AR were more likely to develop cholesteatoma compared to those without AR (adjusted HR 1.57, 95% confidence interval = 1.05-2.34, P < 0.05). Patients with AR presented a significantly lower 10-year cholesteatoma-free survival rate than did those in the comparison group (log-rank, P < 0.001). Conclusion: This is the first study to demonstrate a link between AR and the development of cholesteatoma. We suggest that clinicians keep this association in mind and carefully investigate the possibility of development of cholesteatoma among patients with AR. Level of Evidence: 3b. Laryngoscope, 2016

原文英語
頁(從 - 到)547
頁數553
期刊Laryngoscope
128
發行號3
DOIs
出版狀態已發佈 - 三月 2018

指紋

Cholesteatoma
Survival Rate
Databases
Laryngoscopes
Allergic Rhinitis
Health Insurance
Rhinitis
Taiwan
Population
Cohort Studies
Retrospective Studies
Confidence Intervals
Survival

ASJC Scopus subject areas

  • Otorhinolaryngology

引用此文

Increased risk of cholesteatoma among patients with allergic rhinitis : A nationwide investigation. / Kuo, Chin Lung; Shiao, An Suey; Wen, Hsyien Chia; Chang, Wei Pin.

於: Laryngoscope, 卷 128, 編號 3, 03.2018, p. 547.

研究成果: 雜誌貢獻文章

@article{a50563376bf24ab49944ae593d748a03,
title = "Increased risk of cholesteatoma among patients with allergic rhinitis: A nationwide investigation",
abstract = "Objectives: No large population-based studies have reported on the risk of cholesteatoma developing after allergic rhinitis (AR). This study used a nationwide population-based claims database to investigate the hypothesis that AR may increase the risk of cholesteatoma. Study Design: Retrospective cohort study. Methods: Data from Taiwan's Longitudinal Health Insurance Database were analyzed to compile the following: 1) 15,953 patients newly diagnosed with AR between 1997 and 2000, and 2) a comparison cohort of 63,812 matched non-AR enrollees (with a ratio of 1 to 4). Each patient was followed for 10 years to identify cases in which cholesteatoma subsequently developed. The Kaplan-Meier method was used to determine the cholesteatoma-free survival rate, and the log-rank test was used to compare survival curves. Cox proportional hazard regressions were performed to compute adjusted hazard ratios (HRs). Results: Among the 79,765 patients enrolled in this study, 45 (159,364 person-years) from the AR cohort and 88 (638,130 person-years) from the comparison cohort were diagnosed with cholesteatoma during the follow-up period (incidence rates 0.28 and 0.14 of 1,000 person-years, respectively). Patients with AR were more likely to develop cholesteatoma compared to those without AR (adjusted HR 1.57, 95{\%} confidence interval = 1.05-2.34, P < 0.05). Patients with AR presented a significantly lower 10-year cholesteatoma-free survival rate than did those in the comparison group (log-rank, P < 0.001). Conclusion: This is the first study to demonstrate a link between AR and the development of cholesteatoma. We suggest that clinicians keep this association in mind and carefully investigate the possibility of development of cholesteatoma among patients with AR. Level of Evidence: 3b. Laryngoscope, 2016",
keywords = "Allergic rhinitis, Association, Cholesteatoma, Middle ear, Population",
author = "Kuo, {Chin Lung} and Shiao, {An Suey} and Wen, {Hsyien Chia} and Chang, {Wei Pin}",
year = "2018",
month = "3",
doi = "10.1002/lary.26220",
language = "English",
volume = "128",
pages = "547",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Increased risk of cholesteatoma among patients with allergic rhinitis

T2 - A nationwide investigation

AU - Kuo, Chin Lung

AU - Shiao, An Suey

AU - Wen, Hsyien Chia

AU - Chang, Wei Pin

PY - 2018/3

Y1 - 2018/3

N2 - Objectives: No large population-based studies have reported on the risk of cholesteatoma developing after allergic rhinitis (AR). This study used a nationwide population-based claims database to investigate the hypothesis that AR may increase the risk of cholesteatoma. Study Design: Retrospective cohort study. Methods: Data from Taiwan's Longitudinal Health Insurance Database were analyzed to compile the following: 1) 15,953 patients newly diagnosed with AR between 1997 and 2000, and 2) a comparison cohort of 63,812 matched non-AR enrollees (with a ratio of 1 to 4). Each patient was followed for 10 years to identify cases in which cholesteatoma subsequently developed. The Kaplan-Meier method was used to determine the cholesteatoma-free survival rate, and the log-rank test was used to compare survival curves. Cox proportional hazard regressions were performed to compute adjusted hazard ratios (HRs). Results: Among the 79,765 patients enrolled in this study, 45 (159,364 person-years) from the AR cohort and 88 (638,130 person-years) from the comparison cohort were diagnosed with cholesteatoma during the follow-up period (incidence rates 0.28 and 0.14 of 1,000 person-years, respectively). Patients with AR were more likely to develop cholesteatoma compared to those without AR (adjusted HR 1.57, 95% confidence interval = 1.05-2.34, P < 0.05). Patients with AR presented a significantly lower 10-year cholesteatoma-free survival rate than did those in the comparison group (log-rank, P < 0.001). Conclusion: This is the first study to demonstrate a link between AR and the development of cholesteatoma. We suggest that clinicians keep this association in mind and carefully investigate the possibility of development of cholesteatoma among patients with AR. Level of Evidence: 3b. Laryngoscope, 2016

AB - Objectives: No large population-based studies have reported on the risk of cholesteatoma developing after allergic rhinitis (AR). This study used a nationwide population-based claims database to investigate the hypothesis that AR may increase the risk of cholesteatoma. Study Design: Retrospective cohort study. Methods: Data from Taiwan's Longitudinal Health Insurance Database were analyzed to compile the following: 1) 15,953 patients newly diagnosed with AR between 1997 and 2000, and 2) a comparison cohort of 63,812 matched non-AR enrollees (with a ratio of 1 to 4). Each patient was followed for 10 years to identify cases in which cholesteatoma subsequently developed. The Kaplan-Meier method was used to determine the cholesteatoma-free survival rate, and the log-rank test was used to compare survival curves. Cox proportional hazard regressions were performed to compute adjusted hazard ratios (HRs). Results: Among the 79,765 patients enrolled in this study, 45 (159,364 person-years) from the AR cohort and 88 (638,130 person-years) from the comparison cohort were diagnosed with cholesteatoma during the follow-up period (incidence rates 0.28 and 0.14 of 1,000 person-years, respectively). Patients with AR were more likely to develop cholesteatoma compared to those without AR (adjusted HR 1.57, 95% confidence interval = 1.05-2.34, P < 0.05). Patients with AR presented a significantly lower 10-year cholesteatoma-free survival rate than did those in the comparison group (log-rank, P < 0.001). Conclusion: This is the first study to demonstrate a link between AR and the development of cholesteatoma. We suggest that clinicians keep this association in mind and carefully investigate the possibility of development of cholesteatoma among patients with AR. Level of Evidence: 3b. Laryngoscope, 2016

KW - Allergic rhinitis

KW - Association

KW - Cholesteatoma

KW - Middle ear

KW - Population

UR - http://www.scopus.com/inward/record.url?scp=85026759244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026759244&partnerID=8YFLogxK

U2 - 10.1002/lary.26220

DO - 10.1002/lary.26220

M3 - Article

AN - SCOPUS:85026759244

VL - 128

SP - 547

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 3

ER -